These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
407 related articles for article (PubMed ID: 22314077)
1. TWEAK in inclusion-body myositis muscle: possible pathogenic role of a cytokine inhibiting myogenesis. Morosetti R; Gliubizzi C; Sancricca C; Broccolini A; Gidaro T; Lucchini M; Mirabella M Am J Pathol; 2012 Apr; 180(4):1603-13. PubMed ID: 22314077 [TBL] [Abstract][Full Text] [Related]
2. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells. Ando T; Ichikawa J; Wako M; Hatsushika K; Watanabe Y; Sakuma M; Tasaka K; Ogawa H; Hamada Y; Yagita H; Nakao A Arthritis Res Ther; 2006; 8(5):R146. PubMed ID: 16945157 [TBL] [Abstract][Full Text] [Related]
3. MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle. Morosetti R; Mirabella M; Gliubizzi C; Broccolini A; De Angelis L; Tagliafico E; Sampaolesi M; Gidaro T; Papacci M; Roncaglia E; Rutella S; Ferrari S; Tonali PA; Ricci E; Cossu G Proc Natl Acad Sci U S A; 2006 Nov; 103(45):16995-7000. PubMed ID: 17077152 [TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor inducible 14 (Fn14) is required for the expression of myogenic regulatory factors and differentiation of myoblasts into myotubes. Evidence for TWEAK-independent functions of Fn14 during myogenesis. Dogra C; Hall SL; Wedhas N; Linkhart TA; Kumar A J Biol Chem; 2007 May; 282(20):15000-10. PubMed ID: 17383968 [TBL] [Abstract][Full Text] [Related]
5. HMGB1 expression and secretion are increased via TWEAK-Fn14 interaction in atherosclerotic plaques and cultured monocytes. Moreno JA; Sastre C; Madrigal-Matute J; Muñoz-García B; Ortega L; Burkly LC; Egido J; Martín-Ventura JL; Blanco-Colio LM Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):612-20. PubMed ID: 23288170 [TBL] [Abstract][Full Text] [Related]
6. TWEAK/Fn14 promotes pro-inflammatory cytokine secretion in hepatic stellate cells via NF-κB/STAT3 pathways. Wang A; Zhang F; Xu H; Xu M; Cao Y; Wang C; Xu Y; Su M; Zhang M; Zhuge Y Mol Immunol; 2017 Jul; 87():67-75. PubMed ID: 28411440 [TBL] [Abstract][Full Text] [Related]
7. Expression and function of fibroblast growth factor-inducible 14 in human corneal myofibroblasts. Ebihara N; Nakayama M; Tokura T; Ushio H; Murakami A Exp Eye Res; 2009 Aug; 89(2):256-62. PubMed ID: 19344712 [TBL] [Abstract][Full Text] [Related]
15. Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14 during cardiac remodelling in rats. Mustonen E; Säkkinen H; Tokola H; Isopoussu E; Aro J; Leskinen H; Ruskoaho H; Rysä J Acta Physiol (Oxf); 2010 May; 199(1):11-22. PubMed ID: 20082609 [TBL] [Abstract][Full Text] [Related]
16. Proinflammatory effects of tumour necrosis factor-like weak inducer of apoptosis (TWEAK) on human gingival fibroblasts. Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T Clin Exp Immunol; 2006 Dec; 146(3):540-9. PubMed ID: 17100776 [TBL] [Abstract][Full Text] [Related]
17. Expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 in patients with polymyositis and dermatomyositis. Peng QL; Shu XM; Tian XL; Lu X; Wang GC Arthritis Res Ther; 2014 Jan; 16(1):R26. PubMed ID: 24467773 [TBL] [Abstract][Full Text] [Related]
18. TWEAK-Fn14 pathway activation after exercise in human skeletal muscle: insights from two exercise modes and a time course investigation. Raue U; Jemiolo B; Yang Y; Trappe S J Appl Physiol (1985); 2015 Mar; 118(5):569-78. PubMed ID: 25539934 [TBL] [Abstract][Full Text] [Related]